Subscribe to our Newsletter
Arrives everyday at 9.00 am Pacific Time

Airlinerwatch

No. 1 Newswire for Airline Industry!

Full width home advertisement

Post Page Advertisement [Top]

MEMPHISFollowing the Food and Drug Administration’s approval of Emergency Use Authorization for the Pfizer-BioNTech COVID-19 vaccine, FedEx Express will begin the transport of the vaccine using its FedEx Priority Overnight service supported by FedEx Priority Alert advanced monitoring. 
After months of preparation and close planning with Pfizer, other healthcare companies, and federal and state officials, the first COVID-19 vaccines will move to dosing centers in the United States.

Vaccine distribution will be balanced among major cargo carriers, and FedEx is working closely with healthcare customers to prepare for additional vaccine shipments and transportation of critical vaccine-related supplies.

The FedEx network is well-positioned to handle COVID-19 vaccine shipments around the world with temperature-control solutions, near real-time monitoring capabilities, and a dedicated healthcare team to support the express transportation of vaccines and bioscience shipments.

FedEx SenseAware ID, a Bluetooth low-energy sensor device, will be affixed to vaccine shipments, helping to ensure these temperature-sensitive deliveries move swiftly and safely through the FedEx Express U.S. network with FedEx Priority Overnight service.

From origin to destination, dedicated FedEx Priority Alert customer support agents are using SenseAware monitoring technology to track the location of vaccine shipments in near real-time.

This technology is complemented by the FedEx Surround platform, which leverages artificial intelligence and predictive tools to proactively monitor conditions surrounding the packages, allowing customer support agents to intervene if weather or traffic delays threaten to impede delivery times.

Bottom Ad [Post Page]